Patients with prostate cancer treated in outpatient clinics will be recruited by their urologist physician. Primary Objective: To evaluate the compliance in male patients with prostate cancer treated with Bisphosphonate and that suffered from Osteopenia/osteoporosis. Secondary objectives: To evaluate the compliance of family physicians to prescribe Bisphosphonate for patients upon recommendation by Urologists. To evaluate the overall number of patients treated by Bisphosphonate in the out-patient clinics, To evaluate incidence of osteopenia/osteoporosis in this study population.
Study Type
OBSERVATIONAL
Enrollment
180
Sanofi-aventis administrative office
Netanya, Israel
To evaluate the compliance in male patients with prostate cancer treated with Bisphosphonate and that suffered from Osteopenia/osteoporosis.
Time frame: 6 months
To evaluate the compliance of family physicians to prescribe Bisphosphonate for patients upon recommendation by Urologists.
Time frame: 6 months
To evaluate the overall number of patients treated by Bisphosphonate in the out-patient clinics
Time frame: 6 months
To evaluate incidence of osteopenia/osteoporosis in this study population.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.